Search Results for: crosswise

Looking for an innovative job? OurCrowd portfolio companies hiring like crazy in 2015

Looking for an innovative job? OurCrowd portfolio companies hiring like crazy in 2015

Jan 11, 2015 |

As OurCrowd’s investment deals continuously grow both in size and quantity, our existing portfolio companies are rapidly expanding too. To date, OurCrowd has invested $100M in 56 portfolio companies, many of which won international awards and are widely acclaimed for their innovative products and amazing all-star teams. Just in 2014, over 260 jobs were created within OurCrowd’s portfolio companies, post-investment. So, if you’re hoping to get your foot in the high-tech industry door, dreaming about being part of the exciting startup ecosystem, or know someone looking for a job in the hottest markets, you’ve come to the right place! Check out the listings below to see how you might have the chance to work for some of our awesome portfolio companies and become part of the growing OurCrowd family: Mentad If you are passionate about big data and changing the future of marketing, chances are you belong with Mentad. Sales Partner; New York, USA. Customer Onboarding and Success; New York, USA. Inbound Marketing and Social Media; New York, USA. Outbound Marketing/Lead Generation; New York, USA. Account Manager; New York or Palo Alto, USA. Full Stack...

Read More
OurCrowd Events January-February 2015

OurCrowd Events January-February 2015

Dec 25, 2014 | ,

OurCrowd founder & CEO Jon Medved and team members will be hosting events in the US and Israel in the upcoming weeks, with the CEOs of our new startups and guest speakers. Scroll down to learn more and RSVP, we hope to see you at one of our events. Be sure to RSVP on the links below. Space is limited! February 25th – Tel Aviv, Israel What: Socialize15 hosted by Forbes Israel Featuring: Jon Medved, OurCrowd CEO, who will speak about “How Crowd Funding can become a multiplier force for social impact investing”‏. use OurCrowd’s discounted code: “OURCROWD” When: 9:00AM-4:00PM For more information and registration for the conference click here.​   February 25th – San Diego, CA What: Join us for dinner, startup discussion, and presentation: “How Angels are Changing the Capital Markets.” Featuring: Howard Lindzon, Co-Founder & Chairman of StockTwits; Audrey Jacobs, VP of Americas of OurCrowd When: 7:00PM – 10:00PM For more information and to RSVP, please click here   February 26th – Penn Valley, PA What: Private Reception: “ The Startup Culture of Israel” Featuring:  Jon Medved, OurCrowd Founder & CEO When: 7:30PM-9:30PM For more information, please email Allison@ourcrowd.com   February 26th – Live on...

Read More

OurCrowd Newsletter: September 7th, 2014

Sep 7, 2014

Sales & Support: +1 (877) 848-0964 Startup Roundup SuperDerivatives sold to NYSE operator, Intercontinental Exchange, for $350M Intercontinental Exchange, the company that runs the New York Stock Exchange, has acquired Israel’s SuperDerivatives for $350 million. SuperDerivatives has developed a platform for pricing, risk management and trading in options that the company said is used by nearly all of the world’s major financial institutions. Founded in Israel in 2000, the company’s global development and support center is based in Tel Aviv, and employs about 300 people. Read more about the acquisition here. OurCrowd In The News OurCrowd’s portfolio company Curiyo featured in  PC Magazine here OurCrowd’s portfolio company Surgical Theater featured in  KING 5 News here OurCrowd’s portfolio company Biocatch featured in  ZDNet here OurCrowd’s portfolio company ReWalk featured in  ConsumerAffairs here OurCrowd’s portfolio company Crosswise featured in  Geektime here OurCrowd’s portfolio company Freightos featured in Inc. here OurCrowd Events Jerusalem, Israel OurCrowd investor gathering at new offices in Jerusalem September 11th, 2014 6:30-8:00 PM For accredited investors only Reserve your seat New York, NY Jon Medved speaking at DCF’s E. Coast Family Office & Wealth Management Annual Conference September...

Read More

OurCrowd Newsletter: July 27th, 2014

Jul 27, 2014

Sales & Support: +1 (877) 848-0964 Startup Roundup Atox Bio raises $23M to fund flesh-eating bacteria drug Atox Bio, a biotech startup that develops therapeutics for severe infections, has closed a $23 million investment round. The proceeds will be used for a late-stage clinical study of Atox Bio’s AB103 for treating what researchers call necrotizing soft tissue infections but is commonly known as the “flesh-eating bacteria” and other severe infections. The Ness Ziona-based Israeli startup was founded by two Hebrew University researchers, Raymond Kaempfer and Gila Arad. To read more about the company, click here. OurCrowd In The News OurCrowd’s CEO Jon Medved was featured on Bloomberg TV here OurCrowd’s CEO Jon Medved was featured on CNBC here OurCrowd portfolio company ReWalk featured in Wired here OurCrowd portfolio company  Bizzabo featured in Shalom Life here OurCrowd portfolio company Biocatch featured in Bloomberg.com here OurCrowd portfolio company  Crosswise featured in AdExchange here OurCrowd’s portfolio companies Surgical Theater & ReWalk were featured in Inc. here OurCrowd portfolio company  Nextpeer featured in VentureBeat here OurCrowd Events Los Angeles, CA OurCrowd investor lunch featuring the latest startups we are...

Read More